argus

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDYINE089A0103197,736 Cr

Timeline

Time (IST)TypeMEventSrc
09 Dec, 04:35 pmDr. Reddy's Laboratories Limited has informed the Exchange about General Updatesnse
08 Dec, 12:54 pmDr. Reddy's Laboratories Limited has informed the Exchange about Arrangements for strategic, technical, manufacturing, or marketing tie upnse
08 Dec, 12:50 pmDr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015bse
26 Nov, 06:00 pmDr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015bse
26 Nov, 05:58 pmDr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015bse
26 Nov, 05:55 pmDr. Reddy's Laboratories Limited has informed the Exchange about General Updatesnse
26 Nov, 05:53 pmDr. Reddy's Laboratories Limited has informed the Exchange about General Updatesnse
24 Nov, 03:48 pmDr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 24, 2025, titled "Dr. Reddy s receives European Commission approval for AVT03 (denosumab), a proposed Biosimilar of Prolia® and Xgeva®".nse
24 Nov, 03:40 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
14 Nov, 04:47 pmDr. Reddy's Laboratories Limited has informed the Exchange about General Updatesnse
14 Nov, 04:44 pmDr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015bse
13 Nov, 12:30 pmDr. Reddy's Laboratories Limited has informed the Exchange about Allotment of 7,430 Equity Shares on exercise of Stock Options under ESOPsnse
11 Nov, 06:45 pmThe Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Hackers dupe Dr Reddy's Laboratories of ₹2.16 crore here's how the cyber fraud unfolded. The response from the Company is attached.nse
11 Nov, 01:08 pmDr Reddys Laboratories Ltd - 500124 - Reply To Clarification Sought By BSEbse
10 Nov, 05:45 pmThe Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Hackers dupe Dr Reddy's Laboratories of ₹2.16 crore here's how the cyber fraud unfolded. The response from the Company is awaited.nse
10 Nov, 04:17 pmDr. Reddy's Laboratories Limited has informed the Exchange about change in Managementnse
10 Nov, 04:14 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Change in Managementbse
30 Oct, 11:02 pmDr. Reddy's Laboratories Limited has informed the Exchange about Transcriptnse
30 Oct, 10:58 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
29 Oct, 05:49 pmDr. Reddy's Laboratories Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015'.nse
25 Oct, 10:46 amDr. Reddy's Laboratories Limited has informed the Exchange regarding 'Earnings call recordings'.nse
25 Oct, 10:42 amDr Reddys Laboratories Ltd - 500124 - Announcement Under Regulation 30 - Earnings Call Recordingsbse
24 Oct, 05:02 pmUpdate on Senior Management Personnelnse
24 Oct, 04:55 pmDr. Reddy's Laboratories Limited has informed the Exchange about Investor Presentationnse
24 Oct, 04:53 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
24 Oct, 04:48 pmDr Reddys Laboratories Ltd - 500124 - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025bse
24 Oct, 04:44 pmDr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.nse
24 Oct, 04:42 pmDr Reddys Laboratories Ltd - 500124 - Board Meeting Outcome for Outcome Of Board Meetingbse
21 Oct, 12:10 pmDr. Reddy's Laboratories Limited has informed the Exchange about General Updatesnse
21 Oct, 12:08 pmDr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015bse
16 Oct, 03:31 pmDr Reddys Laboratories Ltd - 500124 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
13 Oct, 02:53 pmDr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 13, 2025, titled "Initmation of Earnings call".nse
13 Oct, 02:52 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
22 Sept, 05:42 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
22 Sept, 03:57 pmDr Reddys Laboratories Ltd - 500124 - Board Meeting Intimation for Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ending On September 30, 2025bse
19 Sept, 11:02 amDr Reddys Laboratories Ltd - 500124 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
19 Sept, 10:59 amDr Reddys Laboratories Ltd - 500124 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011bse
18 Sept, 08:40 pmDr. Reddy's Laboratories Limited has informed the Exchange about General Updatesnse
18 Sept, 08:38 pmDr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015bse
16 Sept, 05:13 pmDr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 16, 2025, titled "Dr. Reddy's launches novel molecule Tegoprazan in India".nse
16 Sept, 05:11 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
15 Sept, 11:33 amDr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of 6475 securities pursuant to ESOP/ESPS at its meeting held on September 15, 2025nse
13 Sept, 10:58 amDr. Reddy's Laboratories Limited has informed the Exchange about General Updatesnse
13 Sept, 10:56 amDr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
10 Sept, 11:25 pmDr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015bse
10 Sept, 11:24 pmDr. Reddy's Laboratories Limited has informed the Exchange about Arrangements for strategic, technical, manufacturing, or marketing tie upnse
06 Sept, 01:06 pmDr. Reddy's Laboratories Limited has informed the Exchange about General Updatesnse
06 Sept, 01:03 pmDr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
04 Sept, 06:19 pmDr. Reddy's Laboratories Limited has informed the Exchange about Action(s) taken or orders passednse
04 Sept, 06:15 pmDr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements)Regulations, 2015bse